YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Biocon

Biocon

BSE: 532523|NSE: BIOCON|ISIN: INE376G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 09, 11:00
375.25
-7.65 (-2%)
VOLUME 125,869
LIVE
NSE
Dec 09, 11:02
375.70
-7.1 (-1.85%)
VOLUME 2,549,798
News on Biocon
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Neutral Biocon; target of Rs 360: Motilal Oswal

12.39 pm | 07 Dec 2021 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 360 in its research report dated December 06, 2021....

Neutral Biocon; target of Rs 360: Motilal Oswal

12.39 pm | 07 Dec 2021 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 360 in its research report dated December 06, 2021....

Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East

11.37 am | 07 Dec 2021 |  Source: PTI

Tabuk Pharmaceutical Manufacturing Company is a fully-owned subsidiary of Astra Industrial Group, a leading pharmaceutical company in the Middle East ...

Biocon Consolidated September 2021 Net Sales at Rs 1,840.40 crore, up 5.48% Y-o-Y

10.22 am | 26 Oct 2021 |  Source: Moneycontrol.com

NULL...

Biocon Standalone September 2021 Net Sales at Rs 364.80 crore, down 34.86% Y-o-Y

9.33 am | 26 Oct 2021 |  Source: Moneycontrol.com

NULL...

Buy Biocon: target of Rs 470: Sharekhan

2.46 pm | 25 Oct 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated October 22, 2021....

Biocon Consolidated September 2021 Net Sales at Rs 1,840.40 crore, up 5.48% Y-o-Y

9.11 am | 25 Oct 2021 |  Source: Moneycontrol.com

NULL...

Biocon Standalone September 2021 Net Sales at Rs 364.80 crore, down 34.86% Y-o-Y

9.11 am | 25 Oct 2021 |  Source: Moneycontrol.com

NULL...

Biocon Consolidated September 2021 Net Sales at Rs 1,840.40 crore, up 5.48% Y-o-Y

6.00 pm | 22 Oct 2021 |  Source: Moneycontrol.com

NULL...

Biocon Consolidated September 2021 Net Sales at Rs 1,840.40 crore, up 5.48% Y-o-Y

6.00 pm | 22 Oct 2021 |  Source: Moneycontrol.com

NULL...

Biocon Standalone September 2021 Net Sales at Rs 364.80 crore, down 34.86% Y-o-Y

6.00 pm | 22 Oct 2021 |  Source: Moneycontrol.com

NULL...

Hold Biocon: target of Rs 400: ICICI Direct

4.14 pm | 27 Jul 2021 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Biocon with a target price of Rs 400 in its research report dated July 23, 2021....

Buy Biocon: target of Rs 470: Sharekhan

10.52 am | 27 Jul 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated July 23, 2021....

Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y

9.11 am | 27 Jul 2021 |  Source: Moneycontrol.com

NULL...

Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y

9.33 am | 26 Jul 2021 |  Source: Moneycontrol.com

NULL...

Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y

10.52 am | 23 Jul 2021 |  Source: Moneycontrol.com

NULL...

Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y

10.50 am | 23 Jul 2021 |  Source: Moneycontrol.com

NULL...

Biocon Q1 PAT seen up 21% YoY to Rs 180.7 cr: ICICI Direct

7.35 pm | 12 Jul 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 13.4 percent Y-o-Y (up 3.1 percent Q-o-Q) to Rs 1,895.3 crore, according to ICICI Direct....

1 2
Quick Links for Biocon
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.